Imagine a future without type 1 diabetes
TrialNet is an international network of leading academic institutions, endocrinologists, physicians, scientists and healthcare teams at the forefront of type 1 diabetes (T1D) research. We offer risk screening for relatives of people with T1D and innovative clinical studies testing ways to slow down and prevent disease progression. Our goal: a future without T1D!
T1D Risk Screening
Offered at no cost to relatives of people with T1D, TrialNet risk screening detects the disease in its earliest stages, so you can take steps to try to change the course of the disease.
Our innovative clinical studies are testing ways to slow down or stop T1D, before and soon after diagnosis.